LeMaitre Vascular, Inc. (LMAT)
79.96
-1.90
(-2.32%)
USD |
NASDAQ |
Aug 24, 16:00
80.00
+0.04
(+0.05%)
Pre-Market: 09:15
LeMaitre Vascular Net Income (Quarterly) : 17.05M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.05M |
| March 31, 2026 | 15.68M |
| December 31, 2025 | 15.58M |
| September 30, 2025 | 17.36M |
| June 30, 2025 | 13.78M |
| March 31, 2025 | 11.01M |
| December 31, 2024 | 11.18M |
| September 30, 2024 | 11.14M |
| June 30, 2024 | 11.83M |
| March 31, 2024 | 9.887M |
| December 31, 2023 | 8.465M |
| September 30, 2023 | 7.502M |
| June 30, 2023 | 8.098M |
| March 31, 2023 | 6.04M |
| December 31, 2022 | 5.627M |
| September 30, 2022 | 5.456M |
| June 30, 2022 | 3.515M |
| March 31, 2022 | 6.038M |
| December 31, 2021 | 6.175M |
| September 30, 2021 | 6.504M |
| June 30, 2021 | 8.299M |
| March 31, 2021 | 5.929M |
| December 31, 2020 | 7.033M |
| September 30, 2020 | 7.513M |
| June 30, 2020 | 3.50M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.174M |
| December 31, 2019 | 4.613M |
| September 30, 2019 | 5.184M |
| June 30, 2019 | 4.624M |
| March 31, 2019 | 3.513M |
| December 31, 2018 | 6.025M |
| September 30, 2018 | 4.314M |
| June 30, 2018 | 8.751M |
| March 31, 2018 | 3.853M |
| December 31, 2017 | 4.284M |
| September 30, 2017 | 5.042M |
| June 30, 2017 | 4.632M |
| March 31, 2017 | 3.219M |
| December 31, 2016 | 2.597M |
| September 30, 2016 | 3.229M |
| June 30, 2016 | 2.598M |
| March 31, 2016 | 2.166M |
| December 31, 2015 | 2.53M |
| September 30, 2015 | 2.092M |
| June 30, 2015 | 1.767M |
| March 31, 2015 | 1.369M |
| December 31, 2014 | 1.916M |
| September 30, 2014 | 0.934M |
| June 30, 2014 | 1.272M |
| March 31, 2014 | -0.207M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Boston Scientific Corp. | 905.00M |
| Abbott Laboratories | 928.00M |
| AngioDynamics, Inc. | -11.40M |
| Alphatec Holdings, Inc. | -25.78M |
| AtriCure, Inc. | 8.955M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 70.38M |
| Total Expenses (Quarterly) | 53.33M |
| EPS Diluted (Quarterly) | 0.695 |
| Enterprise Value | 1.642B |
| Gross Profit Margin (Quarterly) | 70.12% |
| Profit Margin (Quarterly) | 24.22% |
| Earnings Yield | 3.51% |
| Operating Earnings Yield | 4.07% |
| Normalized Earnings Yield | 3.510 |